Noninvasive Hemodynamic Monitoring in Microgravity, Phase II (Arterial Stiffness)

Early detection of cardiovascular changes is of prime importance for assessing astronaut health in space on short and long term missions. Current technologies (echocardiography, ICG) remain complex for routine use. Therefore, a novel non-invasive ballistocardiograph (BCG) based pulse wave velocity (PWV) system is proposed to monitor for cardiovascular deconditioning. This PWV system is suited for both terrestrial and space use. Testing in reduced gravity will provide vital information to relate future microgravity measurements to existing ground studies.

This work is related to T0051-P Non-Invasive Hemodynamic Monitoring in Microgravity.

Early detection of cardiovascular changes is of prime importance for assessing astronaut health in space on short and long term missions. This novel non-invasive cardiovascular monitor will benefit future NASA missions and health care providers for ground-based cardiovascular risk assessments.

This is early/mid-stage (TRL 6) — the most realistic path in is NASA SBIR/STTR, which funds small businesses and research institutions to develop technology aligned with NASA's needs (equity-free, phased funding). Check whether a current SBIR/STTR solicitation topic overlaps with this project's technology area, or contact the project directly (above) to ask.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.